Diebold Nixdorf, Incorporated
DBD · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $3,751,100 | $3,760,500 | $3,460,700 | $3,905,200 |
| % Growth | -0.2% | 8.7% | -11.4% | – |
| Cost of Goods Sold | $2,831,100 | $2,884,300 | $2,703,400 | $2,861,800 |
| Gross Profit | $920,000 | $876,200 | $757,300 | $1,043,400 |
| % Margin | 24.5% | 23.3% | 21.9% | 26.7% |
| R&D Expenses | $93,600 | $110,900 | $120,700 | $126,300 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $643,600 | $0 | $741,600 | $775,600 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $700 | $678,400 | $106,700 | $4,400 |
| Operating Expenses | $737,900 | $789,300 | $969,000 | $906,300 |
| Operating Income | $182,100 | $86,900 | -$211,700 | $137,100 |
| % Margin | 4.9% | 2.3% | -6.1% | 3.5% |
| Other Income/Exp. Net | -$132,300 | $1,365,400 | -$224,700 | -$187,500 |
| Pre-Tax Income | $49,800 | $1,452,300 | -$436,400 | -$50,400 |
| Tax Expense | $64,300 | $75,700 | $149,200 | $27,700 |
| Net Income | -$16,500 | $1,376,100 | -$581,400 | -$78,800 |
| % Margin | -0.4% | 36.6% | -16.8% | -2% |
| EPS | -0.44 | 21.38 | -7.44 | -1 |
| % Growth | -102.1% | 387.4% | -644% | – |
| EPS Diluted | -0.44 | 21.38 | -7.44 | -1 |
| Weighted Avg Shares Out | 37,600 | 64,360 | 79,000 | 78,300 |
| Weighted Avg Shares Out Dil | 37,600 | 64,360 | 79,000 | 78,300 |
| Supplemental Information | – | – | – | – |
| Interest Income | $12,300 | $13,000 | $10,000 | $6,100 |
| Interest Expense | $155,300 | $246,200 | $199,200 | $195,300 |
| Depreciation & Amortization | $132,300 | $126,400 | $126,000 | $149,100 |
| EBITDA | $334,900 | $275,000 | -$113,400 | $293,700 |
| % Margin | 8.9% | 7.3% | -3.3% | 7.5% |